Prostate Cell News Volume 12.11 | Mar 26 2021

    0
    29







    2021-03-29 | PCN 12.11


    Prostate Cell News by STEMCELL Technologies
    Vol. 12.11 – 26 March, 2021
    TOP STORY

    SUMOylation Controls the Binding of Hexokinase 2 to Mitochondria and Protects against Prostate Cancer Tumorigenesis

    Scientists report that SUMOylation regulated the binding of hexokinase 2 to mitochondria. They found that hexokinase 2 could be SUMOylated at K315 and K492.
    [Nature Communications]

    Full Article

    Watch a webinar on using patient-derived iPS cells to model diabetes.
    PUBLICATIONSRanked by the impact factor of the journal

    Stomatin-Mediated Inhibition of the Akt Signaling Axis Suppresses Tumor Growth

    Investigators found that stomatin expression was markedly upregulated by the interaction between prostate cancer cells and stromal cells.
    [Cancer Research]

    Abstract

    A Glutaminase Isoform Switch Drives Therapeutic Resistance and Disease Progression of Prostate Cancer

    The authors report that the androgen receptor promoted glutaminase 1 expression and glutamine utilization to support the survival of prostate cancer cells.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Progression of Prostate Carcinoma Is Promoted by Adipose Stromal Cell-Secreted CXCL12 Signaling in Prostate Epithelium

    Researchers demonstrated that epithelial–mesenchymal transition in prostate tumors was promoted by obesity and suppressed upon pharmacological adipose stromal cells depletion in HiMyc mice, a spontaneous genetic model of prostate cancer.
    [npj Precision Oncology]

    Full Article

    Kinesin Family Member 18B Regulates the Proliferation and Invasion of Human Prostate Cancer Cells

    In vitro, kinesin family member 18B (KIF18B) knockdown in prostate cancer cell lines promoted cell proliferation, migration, and invasion, and inhibited cell apoptosis, while KIF18B overexpression had the opposite effects.
    [Cell Death & Disease]

    Full Article

    FGF21 Facilitates Autophagy in Prostate Cancer Cells by Inhibiting the PI3K–Akt–mTOR Signaling Pathway

    Scientists investigated the action of fibroblast growth factor 21 (FGF21) in the development of prostate cancer (PCa). They found that FGF21 expression was markedly downregulated in PCa tissues and cell lines.
    [Cell Death & Disease]

    Full Article

    PCA3 Controls Chromatin Organization and p53 Signal Activation by Regulating LAP2α-Lamin a Complexes

    Researchers report that lncRNA Prostate cancer antigen 3 (PCA3) played a role in prostate cancer progression that was mediated by nucleoplasmic lamins.
    [Cancer Gene Therapy]

    Abstract

    CASC11 Promotes Aggressiveness of Prostate Cancer Cells through miR-145/IGF1R Axis

    The authors explored the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of prostate cancer cells.
    [Prostate Cancer and Prostatic Diseases]

    Abstract

    Pin1 Inhibition Improves the Efficacy of Ralaniten Compounds That Bind to the N-Terminal Domain of Androgen Receptor

    Investigators showed that Pin1 interacted with the androgen receptor (AR) N-terminal domain. The inhibition of Pin1 expression or its activity selectively reduced the transcriptional activities of full-length AR and AR- splice variant 7.
    [Communications Biology]

    Full Article

    EZH2 Inhibition Activates a dsRNA–STING–Interferon Stress Axis That Potentiates Response to PD-1 Checkpoint Blockade in Prostate Cancer

    Scientists demonstrated that enhancer of zeste homolog-2 (EZH2) inhibition in prostate cancer models activated a double-stranded RNA–STING–ISG stress response upregulating genes involved in antigen presentation, Th1 chemokine signaling, and interferon response, including programmed cell death protein 1 (PD-L1) that was dependent on STING activation.
    [Nature Cancer]

    Abstract

    Using CT-Guided Stereotactic Prostate Radiation Therapy (CT-SPRT) to Assess Sustained Murine Prostate Ablation

    Investigators designed a novel computed tomography (CT)–SPRT technique to deliver a single high-dose 25 Gy fraction of X-ray radiation.
    [Scientific Reports]

    Full Article

    Enter a contest to win a personalized lab coat by subscribing to Organoid News!
    REVIEWS

    Resistance to Second-Generation Androgen Receptor Antagonists in Prostate Cancer

    Ongoing research to establish predictive biomarkers for the treatment of tumors with resistance to second-generation androgen receptor antagonists led to the approval of the PARP inhibitors olaparib and rucaparib in pre-treated metastatic castration-resistant prostate cancer.
    [Nature Reviews Urology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Myovant Sciences Announces Recipients of “Forward for Health Equity” Grants to Improve Healthcare Access in Prostate Cancer and Uterine Fibroids

    Myovant Sciences announced the four recipients of its Forward for Health Equity grants. The grant program provides funding to nonprofit healthcare organizations with innovative projects focused on improving healthcare access, with an initial focus on reducing racial disparities in prostate cancer and uterine fibroids in the US.
    [Myovant Sciences]

    Press Release

    Bio-Techne’s Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test

    Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, has completed its clinical validation of an in vitro diagnostic (IVD) version of the ExoDx Prostate test kit enabling self-certification as CE-IVD.
    [Bio-Techne Corporation]

    Press Release

    FEATURED EVENT

    ISSCR: Stem Cells and Regenerative Medicine

    January 12 – 14, 2022
    Shanghai, China

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Hormone-Refractory Prostate Cancer

    Virginia Commonwealth University – Richmond, Virginia, United States

    Medicinal Chemist – Muscle-Wasting, Neurodegeneration, and Oncology

    Almac – Belfast, Ireland

    Tier I Canada Research Chair – Precision & Molecular Oncology

    University of Calgary – Calgary, Alberta, Canada

    Postdoctoral Scholar Position – Hormone Therapy Resistance in Prostate Cancer

    Duke University – Durham, North Carolina, United States

    Postdoctoral Position – Prostate Cancer Biology

    Weill Cornell Medicine – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter